| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031738 |
| Receipt No. | R000036239 |
| Official scientific title of the study | A study of effect of food containing plant ingredient on skin temperature |
| Date of disclosure of the study information | 2019/03/12 |
| Last modified on | 2018/03/15 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A study of effect of food containing plant ingredient on skin temperature | |
| Title of the study (Brief title) | A study of effect of food containing plant ingredient on skin temperature | |
| Region |
|
|
| Condition | |||
| Condition | None | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the effect of food containing plant ingredient on skin temperature |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin temperature |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of food containing plant ingredient component food | |
| Interventions/Control_2 | Ingestion of food containing plant ingredient component food | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Japanese subjects of both sexes above 20 years old- under 65 years old at the point of obtaining informed consent
2)Subjects who competent to consent and give voluntary consent in writing with full understanding after receiving explanation of this study aim and contents. |
|||
| Key exclusion criteria | 1)Subjects who is under treatment.
2)Subjects who have risk to develop allergy. 3)Subjects who have serious diabetes, hepatic disorder (liver inflammation), kidney disorder, and cardiac disorder, or subjects who have history of medication for thyroid disorder, adrenal gland disorder, and other metabolic disease 4)Subjects who are willing to become pregnant or lactation during this study 5)Subjects who participated in other clinical trial within 1 month prior to obtaining informed consent, or subjects who are planning to participate other clinical trial during this study |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Ashigai |
| Organization | Kirin Company, Limited |
| Division name | Research Laboratories for Health Science and Food Technologies Research and Development Division |
| Address | 1-17-1,Namamugi,Tsurumi-ku,Yokohama 230-8628 Japan |
| TEL | 080-1930-9950 |
| Hiroshi_Ashigai@kirin.co.jp | |
| Public contact | |
| Name of contact person | Hiroshi Ashigai |
| Organization | Kirin Company, Limited |
| Division name | Research Laboratories for Health Science and Food Technologies Research and Development Division |
| Address | 1-17-1,Namamugi,Tsurumi-ku,Yokohama 230-8628 Japan |
| TEL | 080-1930-9950 |
| Homepage URL | |
| Hiroshi_Ashigai@kirin.co.jp | |
| Sponsor | |
| Institute | Kirin Company, Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kirin Company, Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036239 |